The raw feed
Latest filings
Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.
| Date | Company | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2025 | EPIX ESSA Pharma Inc. | Bvf Partners L P/il owner | XIn-the-money exercise Pre-funded Warrantsderivative | -203,336 | $0.00 | $0 | 0 | Aug 7, 2025 |
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | Michael S Gordon owner | XIn-the-money exercise Common Shares, no par valueindirect: By Title 19 Promis | +119,800 | - | - | 2,195,429 | Jul 29, 2025 |
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | Michael S Gordon owner | XIn-the-money exercise Common Shares, no par valueindirect: By Title 19 Promis | +119,800 | - | - | 2,315,229 | Jul 29, 2025 |
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | Michael S Gordon owner | XIn-the-money exercise Common Shares, no par valueindirect: By Title 19 Promis | +119,800 | - | - | 2,435,029 | Jul 29, 2025 |
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | Michael S Gordon owner | XIn-the-money exercise Tranche A Common Share Purchase Warrantsderivativeindirect: See footnote | -119,800 | $0.00 | $0 | 345,316 | Jul 29, 2025 |
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | Michael S Gordon owner | XIn-the-money exercise Tranche B Common Share Purchase Warrantsderivativeindirect: See footnote | -119,800 | $0.00 | $0 | 345,316 | Jul 29, 2025 |
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | Michael S Gordon owner | XIn-the-money exercise Tranche C Common Share Purchase Warrantsderivativeindirect: See footnote | -119,800 | $0.00 | $0 | 345,316 | Jul 29, 2025 |
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | Title 19 Promis owner | XIn-the-money exercise Common Shares, no par value | +119,800 | - | - | 2,195,429 | Jul 29, 2025 |
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | Title 19 Promis owner | XIn-the-money exercise Common Shares, no par value | +119,800 | - | - | 2,315,229 | Jul 29, 2025 |
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | Title 19 Promis owner | XIn-the-money exercise Common Shares, no par value | +119,800 | - | - | 2,435,029 | Jul 29, 2025 |
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | Title 19 Promis owner | XIn-the-money exercise Tranche A Common Share Purchase Warrantsderivative | -119,800 | $0.00 | $0 | 345,316 | Jul 29, 2025 |
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | Title 19 Promis owner | XIn-the-money exercise Tranche B Common Share Purchase Warrantsderivative | -119,800 | $0.00 | $0 | 345,316 | Jul 29, 2025 |
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | Title 19 Promis owner | XIn-the-money exercise Tranche C Common Share Purchase Warrantsderivative | -119,800 | $0.00 | $0 | 345,316 | Jul 29, 2025 |
| Jul 28, 2025 | KVYO Klaviyo, Inc. | Shopify Strategic Holdings 3 LLC owner | XIn-the-money exercise Warrants to Purchase Series B Common Stock (Right to Buy)derivative | -344,383 | $0.00 | $0 | 2,755,057 | Jul 29, 2025 |
| Jul 28, 2025 | KVYO Klaviyo, Inc. | Shopify Strategic Holdings 3 LLC owner | XIn-the-money exercise Series B Common Stockderivative | +344,383 | $0.01 | $3,444 | 15,939,963 | Jul 29, 2025 |
| Jul 23, 2025 | FLL FULL HOUSE RESORTS INC | Daniel R Lee Chief Executive Officer | XIn-the-money exercise Common Stock | +184,200 | $4.75 | $875k | 1,260,918 | Jul 24, 2025 |
| Jul 23, 2025 | FLL FULL HOUSE RESORTS INC | Daniel R Lee Chief Executive Officer | XIn-the-money exercise Put Option (obligation to purchase)derivative | -184,200 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jun 29, 2025 | NSPR InspireMD, Inc. | Michael Berman director | XIn-the-money exercise Common Stockindirect: See Footnote | +61,248 | $1.38 | $85k | 244,994 | Jul 23, 2025 |
| Jun 29, 2025 | NSPR InspireMD, Inc. | Michael Berman director | XIn-the-money exercise Series I Warrant (right to buy)derivativeindirect: See Footnote | -61,248 | $0.00 | $0 | 0 | Jul 23, 2025 |
| Jul 11, 2025 | NSPR InspireMD, Inc. | Thomas J Kester director | XIn-the-money exercise Common Stock | +30,624 | $1.38 | $42k | 389,767 | Jul 23, 2025 |
| Jul 11, 2025 | NSPR InspireMD, Inc. | Thomas J Kester director | XIn-the-money exercise Series I Warrant (right to buy)derivative | -30,624 | $0.00 | $0 | 0 | Jul 23, 2025 |
| Jul 1, 2025 | NSPR InspireMD, Inc. | Paul Stuka director | XIn-the-money exercise Common Stockindirect: See Footnote | +87,500 | $1.38 | $121k | 423,534 | Jul 23, 2025 |
| Jul 1, 2025 | NSPR InspireMD, Inc. | Paul Stuka director | XIn-the-money exercise Series I Warrant (right to buy)derivativeindirect: See Footnote | -87,500 | $0.00 | $0 | 0 | Jul 23, 2025 |
| Jun 25, 2025 | NSPR InspireMD, Inc. | Gary S Roubin director | XIn-the-money exercise Common Stock | +30,624 | $1.38 | $42k | 567,103 | Jul 23, 2025 |
| Jun 25, 2025 | NSPR InspireMD, Inc. | Gary S Roubin director | XIn-the-money exercise Series I Warrant (right to buy)derivative | -30,624 | $0.00 | $0 | 0 | Jul 23, 2025 |
| Jun 11, 2025 | PBT PERMIAN BASIN ROYALTY TRUST | Eric L Oliver owner | XIn-the-money exercise Units of Beneficial Ownershipindirect: By SoftVest, LP | +1,000 | $12.50 | $13k | 6,066,000 | Jul 22, 2025 |
| Jun 12, 2025 | PBT PERMIAN BASIN ROYALTY TRUST | Eric L Oliver owner | XIn-the-money exercise Units of Beneficial Ownershipindirect: By SoftVest, LP | +20,300 | $12.50 | $254k | 6,108,300 | Jul 22, 2025 |
| Jun 20, 2025 | PBT PERMIAN BASIN ROYALTY TRUST | Eric L Oliver owner | XIn-the-money exercise Units of Beneficial Ownershipindirect: By SoftVest, LP | +23,300 | $12.50 | $291k | 6,162,423 | Jul 22, 2025 |
| Jun 11, 2025 | PBT PERMIAN BASIN ROYALTY TRUST | Eric L Oliver owner | XIn-the-money exercise Short Put Option (Obligation to buy)derivativeindirect: By SoftVest, LP | -10 | $0.00 | $0 | 38,600 | Jul 22, 2025 |
| Jun 12, 2025 | PBT PERMIAN BASIN ROYALTY TRUST | Eric L Oliver owner | XIn-the-money exercise Short Put Option (Obligation to buy)derivativeindirect: By SoftVest, LP | -20 | $0.00 | $0 | 23,300 | Jul 22, 2025 |
| Jun 20, 2025 | PBT PERMIAN BASIN ROYALTY TRUST | Eric L Oliver owner | XIn-the-money exercise Short Put Option (Obligation to buy)derivativeindirect: By SoftVest, LP | -23 | $0.00 | $0 | 0 | Jul 22, 2025 |
| Jul 18, 2025 | NBR NABORS INDUSTRIES LTD | Varde Partners Inc owner | XIn-the-money exercise Common Sharesindirect: See footnotes | -295,500 | $30.00 | $8.9M | 1,718,430 | Jul 22, 2025 |
| Jul 18, 2025 | NBR NABORS INDUSTRIES LTD | Varde Partners Inc owner | XIn-the-money exercise Option (Obligation to sell)derivativeindirect: See footnotes | -2,955 | $0.00 | $0 | 3,745 | Jul 22, 2025 |
| Jul 17, 2025 | BWB Bridgewater Bancshares Inc | Lisa M Salazar CHIEF OPERATING OFFICER | XIn-the-money exercise Option to buyderivative | -1,931 | $0.00 | $0 | 22,297 | Jul 18, 2025 |
| Jul 14, 2025 | MNPR Monopar Therapeutics | Kim R Tsuchimoto Chief Financial Officer | XIn-the-money exercise Common Stock | +8,904 | $0.01 | $45 | 20,390 | Jul 16, 2025 |
| Jul 14, 2025 | MNPR Monopar Therapeutics | Kim R Tsuchimoto Chief Financial Officer | XIn-the-money exercise Stock Optionsderivative | -4,200 | $0.00 | $0 | 0 | Jul 16, 2025 |
| Jul 14, 2025 | MNPR Monopar Therapeutics | Kim R Tsuchimoto Chief Financial Officer | XIn-the-money exercise Stock Optionsderivative | -4,704 | $0.00 | $0 | 0 | Jul 16, 2025 |
| Jul 14, 2025 | MNPR Monopar Therapeutics | Christopher M Starr director | XIn-the-money exercise Common Stock | +16,800 | $0.01 | $84 | 21,973 | Jul 16, 2025 |
| Jul 14, 2025 | MNPR Monopar Therapeutics | Christopher M Starr director | XIn-the-money exercise Stock Optionsderivative | -16,800 | $0.00 | $0 | 0 | Jul 16, 2025 |
| Jul 14, 2025 | MNPR Monopar Therapeutics | Chandler Robinson Chief Executive Officer | XIn-the-money exercise Common Stock | +16,800 | $0.01 | $84 | 90,272 | Jul 16, 2025 |
| Jul 14, 2025 | MNPR Monopar Therapeutics | Chandler Robinson Chief Executive Officer | XIn-the-money exercise Stock Optionsderivative | -16,800 | $0.00 | $0 | 0 | Jul 16, 2025 |
| Jul 11, 2025 | DLTR DOLLAR TREE, INC. | Paul C Hilal director | XIn-the-money exercise Call Option on Share Forward Transactionsderivativeindirect: See footnotes | -900,360 | $0.00 | $0 | 0 | Jul 15, 2025 |
| Jul 11, 2025 | DLTR DOLLAR TREE, INC. | Paul C Hilal director | XIn-the-money exercise Share Forward Transactionsderivativeindirect: See footnotes | +900,360 | $98.00 | $88M | 900,360 | Jul 15, 2025 |
| Jul 11, 2025 | DLTR DOLLAR TREE, INC. | Paul C Hilal director | XIn-the-money exercise Call Option on Share Forward Transactionsderivativeindirect: See footnotes | -636,151 | $0.00 | $0 | 0 | Jul 15, 2025 |
| Jul 11, 2025 | DLTR DOLLAR TREE, INC. | Paul C Hilal director | XIn-the-money exercise Share Forward Transactionsderivativeindirect: See footnotes | +636,151 | $81.00 | $52M | 636,151 | Jul 15, 2025 |
| Jul 11, 2025 | DLTR DOLLAR TREE, INC. | Paul C Hilal director | XIn-the-money exercise Call Option on Cash Settled Share Forward Transactionsderivativeindirect: See footnotes | -2,501,339 | $0.00 | $0 | 0 | Jul 15, 2025 |
| Jul 11, 2025 | DLTR DOLLAR TREE, INC. | Paul C Hilal director | XIn-the-money exercise Cash Settled Share Forward Transactionsderivativeindirect: See footnotes | +2,501,339 | $98.00 | $245M | 2,501,339 | Jul 15, 2025 |
| Jul 11, 2025 | DLTR DOLLAR TREE, INC. | Paul C Hilal director | XIn-the-money exercise Call Option on Cash Settled Share Forward Transactionsderivativeindirect: See footnotes | -6,231,104 | $0.00 | $0 | 0 | Jul 15, 2025 |
| Jul 11, 2025 | DLTR DOLLAR TREE, INC. | Paul C Hilal director | XIn-the-money exercise Cash Settled Share Forward Transactionsderivativeindirect: See footnotes | +6,231,104 | $81.00 | $505M | 6,231,104 | Jul 15, 2025 |
| May 20, 2025 | RCAT Red Cat Holdings, Inc. | Nicholas Reyland Liuzza JR director | XIn-the-money exercise Common Stock | +100,000 | $1.50 | $150k | 487,754 | Jul 9, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.